CLOTINIL-AP 150

CLOTINIL-AP 150 is a fixed-dose combination of Clopidogrel (75 mg) and Aspirin (150 mg), both antiplatelet agents used to prevent the formation of harmful blood clots. This combination is highly effective in reducing the risk of heart attacks, strokes, and other cardiovascular events in patients with a history of heart disease or related conditions.

Key Features:

• Dual antiplatelet therapy for enhanced clot prevention

• Clopidogrel 75 mg: Prevents platelet aggregation

• Aspirin 150 mg: Inhibits thromboxane A2 to reduce clot formation

• Used for secondary prevention of cardiovascular events

• Convenient once-daily tablet formulation